Global Duchenne Muscular Dystrophy Market Opportunities and Forecast 2022-2028
Report Code: KNJ1111836
Publisher: Date of Publish:
No. of Pages: 134 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
This report provides a comprehensive analysis of current global Duchenne Muscular Dystrophy market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Duchenne Muscular Dystrophy industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies. According to this survey, the global Duchenne Muscular Dystrophy market is estimated at $ 1350 million in 2021, and projected to grow at a CAGR of 47.7% to $ 20700 million by 2028. Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Duchenne Muscular Dystrophy Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Duchenne Muscular Dystrophy market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information. The Global Duchenne Muscular Dystrophy Market has been exhibited in detail in the following chapters Chapter 1 displays the basic product introduction and market overview. Chapter 2 provides the competition landscape of global Duchenne Muscular Dystrophy industry. Chapter 3 provides the market analysis by type and by region Chapter 4 provides the market analysis by application and by region Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis. Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. Chapter 12 provides the market forecast by type and by application Chapter 13 provides the market forecast by region Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis. Chapter 15 conclusions Segmented by Type Exondys 51 Emflaza Segmented by Application Hospitals Clinics Home Care Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey PTC Therapeutics Pfizer Italfarmaco Bristol-Myers Squibb
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Duchenne Muscular Dystrophy Market Status and Forecast (2016-2027) 1.3.2 Global Duchenne Muscular Dystrophy Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global Duchenne Muscular Dystrophy Supply by Company 2.1 Global Duchenne Muscular Dystrophy Sales Volume by Company 2.2 Global Duchenne Muscular Dystrophy Sales Value by Company 2.3 Global Duchenne Muscular Dystrophy Price by Company 2.4 Duchenne Muscular Dystrophy Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional Duchenne Muscular Dystrophy Market Status by Type 3.1 Duchenne Muscular Dystrophy Type Introduction 3.1.1 Exondys 51 3.1.2 Emflaza 3.1.3 Translarna 3.2 Global Duchenne Muscular Dystrophy Market by Type 3.2.1 Global Duchenne Muscular Dystrophy Sales Volume by Type (2016-2021) 3.2.2 Global Duchenne Muscular Dystrophy Sales Value by Type (2016-2021) 3.2.3 Global Duchenne Muscular Dystrophy Price by Type (2016-2021) 3.3 North America: by Type 3.4 Europe: by Type 3.5 Asia Pacific: by Type 3.6 Central & South America: by Type 3.7 Middle East & Africa: by Type 4 Global and Regional Duchenne Muscular Dystrophy Market Status by Application 4.1 Duchenne Muscular Dystrophy Segment by Application 4.1.1 Hospitals 4.1.2 Clinics 4.1.3 Home Care 4.2 Global Duchenne Muscular Dystrophy Market by Application 4.2.1 Global Duchenne Muscular Dystrophy Sales Volume by Application (2016-2021) 4.2.2 Global Duchenne Muscular Dystrophy Sales Value by Application (2016-2021) 4.2.3 Global Duchenne Muscular Dystrophy Price by Application (2016-2021) 4.3 North America: by Application 4.4 Europe: by Application 4.5 Asia Pacific: by Application 4.6 Central & South America: by Application 4.7 Middle East & Africa: by Application 5 Global Duchenne Muscular Dystrophy Market Status by Region 5.1 Global Duchenne Muscular Dystrophy Market by Region 5.1.1 Global Duchenne Muscular Dystrophy Sales Volume by Region 5.1.2 Global Duchenne Muscular Dystrophy Sales Value by Region 5.2 North America Duchenne Muscular Dystrophy Market Status 5.3 Europe Duchenne Muscular Dystrophy Market Status 5.4 Asia Pacific Duchenne Muscular Dystrophy Market Status 5.5 Central & South America Duchenne Muscular Dystrophy Market Status 5.6 Middle East & Africa Duchenne Muscular Dystrophy Market Status 6 North America Duchenne Muscular Dystrophy Market Status 6.1 North America Duchenne Muscular Dystrophy Market by Country 6.1.1 North America Duchenne Muscular Dystrophy Sales Volume by Country (2016-2021) 6.1.2 North America Duchenne Muscular Dystrophy Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe Duchenne Muscular Dystrophy Market Status 7.1 Europe Duchenne Muscular Dystrophy Market by Country 7.1.1 Europe Duchenne Muscular Dystrophy Sales Volume by Country (2016-2021) 7.1.2 Europe Duchenne Muscular Dystrophy Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific Duchenne Muscular Dystrophy Market Status 8.1 Asia Pacific Duchenne Muscular Dystrophy Market by Country 8.1.1 Asia Pacific Duchenne Muscular Dystrophy Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Duchenne Muscular Dystrophy Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America Duchenne Muscular Dystrophy Market Status 9.1 Central & South America Duchenne Muscular Dystrophy Market by Country 9.1.1 Central & South America Duchenne Muscular Dystrophy Sales Volume by Country (2016-2021) 9.1.2 Central & South America Duchenne Muscular Dystrophy Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa Duchenne Muscular Dystrophy Market Status 10.1 Middle East & Africa Duchenne Muscular Dystrophy Market by Country 10.1.1 Middle East & Africa Duchenne Muscular Dystrophy Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Duchenne Muscular Dystrophy Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Duchenne Muscular Dystrophy Manufacturing Cost Analysis 11.5 Duchenne Muscular Dystrophy Sales Channel and Distributors Analysis 11.5.1 Duchenne Muscular Dystrophy Sales Channel 11.5.2 Duchenne Muscular Dystrophy Distributors 11.6 Duchenne Muscular Dystrophy Downstream Major Buyers 12 Global Duchenne Muscular Dystrophy Market Forecast by Type and by Application 12.1 Global Duchenne Muscular Dystrophy Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Duchenne Muscular Dystrophy Forecast by Type 12.2.1 Global Duchenne Muscular Dystrophy Sales Volume Forecast by Type 12.2.2 Global Duchenne Muscular Dystrophy Sales Value Forecast by Type 12.2.3 Global Duchenne Muscular Dystrophy Price Forecast by Type 12.3 Global Duchenne Muscular Dystrophy Forecast by Application 12.3.1 Global Duchenne Muscular Dystrophy Sales Volume Forecast by Application 12.3.2 Global Duchenne Muscular Dystrophy Sales Value Forecast by Application 12.3.3 Global Duchenne Muscular Dystrophy Price Forecast by Application 13 Global Duchenne Muscular Dystrophy Market Forecast by Region/Country 13.1 Global Duchenne Muscular Dystrophy Market Forecast by Region (2022-2027) 13.1.1 Global Duchenne Muscular Dystrophy Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Duchenne Muscular Dystrophy Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Sarepta Therapeutics 14.1.1 Company Information 14.1.2 Duchenne Muscular Dystrophy Product Introduction 14.1.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Santhera Pharmaceuticals 14.2.1 Company Information 14.2.2 Duchenne Muscular Dystrophy Product Introduction 14.2.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 PTC Therapeutics 14.3.1 Company Information 14.3.2 Duchenne Muscular Dystrophy Product Introduction 14.3.3 PTC Therapeutics Duchenne Muscular Dystrophy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Pfizer 14.4.1 Company Information 14.4.2 Duchenne Muscular Dystrophy Product Introduction 14.4.3 Pfizer Duchenne Muscular Dystrophy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Italfarmaco 14.5.1 Company Information 14.5.2 Duchenne Muscular Dystrophy Product Introduction 14.5.3 Italfarmaco Duchenne Muscular Dystrophy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Bristol-Myers Squibb 14.6.1 Company Information 14.6.2 Duchenne Muscular Dystrophy Product Introduction 14.6.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis ... 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com